ATLANTA — The jury is still out regarding a potential link between the quadrivalent meningococcal conjugate vaccine and Guillain-Barré syndrome, but new data from the Centers for Disease Control and Prevention provide some reassurance in favor of the vaccine's safety.
PREVIEW